CML is a myeloproliferative disorder, which often arises when a hematopoietic stem cell acquires a translocation mutation between chromosomes 22 and 9, resulting in the fusion of the BCR-ABL oncogene. Here, ABL1 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.